Assessment of Complications, Quality of Life and Easiness of Use of Implantable Central Venous Access Ports

N/ACompletedNCT00921141

Centre Oscar Lambret815 enrolled

Overview

This is a prospective, descriptive and observational study of the anticancer center practice

Study Type

OBSERVATIONAL

Enrollment

815

Conditions

Cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient with any cancer, requiring a central venous catheter * No contraindication for any surgery with local or complete anaesthesia Exclusion Criteria: * Previous Xylocaine or Lidocaine allergy * Clinic superior vena cava syndrome

Locations (1)

Centre Oscar Lambret

Lille, France

Outcomes

Primary Outcomes

Incidence and collection of complications for the patients requiring an implantable central venous access ports substitution/change

Time frame: Until the implantable central venous access ports removal

Secondary Outcomes

Brief description of the different risk factor for morbidity

Time frame: Until the implantable central venous access ports removal

Assessment of the implantable central venous access ports ease-of-use for nurses according to the modalities of implementation and patient features

Time frame: Until the implantable central venous access ports removal

Assessment of the patient quality of life

Time frame: Before central venous access ports implementation, at the first day of chemotherapy, and during the cycle 4 of chemotherapy

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.